Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Additional toxicological data

Currently viewing:

Administrative data

additional toxicological information
Type of information:
experimental study
Adequacy of study:
key study
Study period:
12-16 January 1987
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: No GLP study. There is no standardized protocol for conducting photoirritancy screening in humans. The laboratory used its own protocol.

Data source

Reference Type:
study report
Report date:

Materials and methods

Type of study / information:
Photo irritancy
Principles of method if other than guideline:
The photoirritancy was tested on 10 human volunteers. AHTN was applied to several sites on the skin. Part of the sites were irradiated and the other sites non-irradiated. The skin evaluated at different time intervals. A positive control was also employed.
GLP compliance:

Test material

Constituent 1
Chemical structure
Reference substance name:
EC Number:
EC Name:
Cas Number:
Molecular formula:
Details on test material:

Results and discussion

Any other information on results incl. tables

 There were no significant reactions to the AHTN solution but all three subjects exposed to 8-MOP (positive control) showed clear positive reactions.

Applicant's summary and conclusion

AHTN is not photo-irritant to humans.
Executive summary:

AHTN (Tonalid®; non-GLP, purity >98% - 10% dilution in ethanol/DEP (3:1)) was tested for photoirritancy on 10 female human volunteers (white Caucasian; ages 18-39). Before application of the preparation for each of the subjects, the Minimal Erythemal Dose (MED) was determined using UV light irradiation from a xenon arc solar light simulator. Subsequently, areas on the back were stripped 3 times to remove the superficial stratum corneum; followed by application of 20μL of the test solution to 3 designated test sites, each approximately 1.5 cm in diameter. One of the sites was used as the non-irradiated control site and one site was irradiated but was not treated with AHTN. In addition, three of the 10 subjects were randomly selected and treated with 20μL of a 0.2 mg/ml solution of 8-methoxypsoralen in ethanol as a positive control. After 30 min of contact, one AHTN-treated site and the site not treated with AHTN were irradiated with 10 MED of UV-A followed by 0.5 MED of UVA + UVB The sites were scored 5 min after irradiation and again at 3, 24, 48 and 73 hr after irradiation. There were no significant reactions to the AHTN solution but all three subjects exposed to 8-MOP showed clear positive reactions.

Source: EU Risk Assessment Report AHTN, ECB May 2008